MOLO lands £250k pre-seed to cut parents' mental load with automated reminders
This article covers MOLO, a healthtech startup, which has raised £250k in a pre-seed funding round from Womankind Ventures, Alma Angels, NoBa Capital and a group of angel investors. The funding will support product development, team growth and efforts to expand access for families managing the cognitive and logistical demands of modern parenting.
MOLO, a healthtech startup, has raised £250,000 in a pre-seed funding round from Womankind Ventures, Alma Angels, NoBa Capital and a group of individual angel investors. The investment will fund further product development, team growth and efforts to expand access to families managing the cognitive and logistical demands of modern parenting.
Why it matters
Parents routinely carry a large “mental load” of tasks and planning that can contribute to stress and burnout. Early-stage funding for products that aim to reduce that burden signals investor interest in preventive, everyday mental-health support for families rather than crisis-driven care.
MOLO targets that space by focusing on the background work of family life — the reminders, coordination and decisions that often live in parents’ heads — and attempting to make that work less taxing without adding new administrative overhead.
Inside the product
MOLO was developed from lived experience and research into family dynamics. The platform is described as working with the tools families already use and built with input from psychologists and parents. Its stated goal is to automate or surface routine cognitive and logistical tasks so parents spend less time managing the mechanics of family life.
The company says the funds will be used to continue product development, expand the team and increase access for families. At this stage the proposition is reducing friction in daily routines rather than providing clinical interventions.
Who are the investors?
The round comprises venture and angel capital: Womankind Ventures, Alma Angels, NoBa Capital and a number of individual angels. The raise was managed via FounderCatalyst’s platform, which MOLO used to assemble a group of aligned investors at pre-seed stage.
No lead investor was named in the announcement. The capital is positioned to support near-term product work and go-to-market activity as MOLO seeks traction with family users.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
In the announcement, Sophie Bruce, Founder & CEO at MOLO, said:
This raise allows us to keep building a support system that feels personal, proactive, and genuinely helpful, not another thing for parents to manage.
Bruce framed MOLO as the outcome of both lived experience and research into how families function under pressure, and as a product intended to feel low-friction for users.
The bigger picture
This investment is a small but specific example of early-stage interest in healthtech solutions that sit at the intersection of mental wellbeing and daily life. For UK and European investors, tools that address parental workload and routine support offer a different angle on digital health: lower-risk, high-frequency use cases that aim to prevent stress rather than treat acute conditions.
As MOLO develops its product and looks for user traction, the round underscores how founders and investors are exploring a broader palette of healthtech opportunities beyond clinical care.
They've invested in MOLO
Get to know these healthtech investors
Click here for a full list of 7,526+ startup investors in the UK